ProMIS Neurosciences, Inc. Stock price Toronto S.E.
Equities
PMN
CA74346M4065
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 48.82M 36.05M |
---|---|---|---|---|---|
Net income 2023 * | -17M -12.55M | Net income 2024 * | -28M -20.68M | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-1.78
x | P/E ratio 2024 * |
-1.86
x | Employees | 7 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.55% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 21-05-12 |
Neil Cashman
FOU | Founder | 72 | 04-01-22 |
Eugene Williams
CHM | Chairman | 64 | 15-06-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 14-03-07 |
Neil Cashman
FOU | Founder | 72 | 04-01-22 |
Neil Warma
CEO | Chief Executive Officer | 61 | 21-05-12 |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |